Cited 0 times in
MGMT Gene Promoter Methylation as a Potent Prognostic Factor in Glioblastoma Treated with Temozolomide-Based Chemoradiotherapy: A Single-Institution Study
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.